Search

everythinglearnresearchcommunity

for

Search:↓

Hydrogel with M2-derived exosomes improves wound healing by slowly releasing exosomes that help reduce inflammation and promote tissue repair.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Deleting podoplanin in mice promotes hair growth by enhancing cell migration.

Camellia japonica extract may improve scalp health and promote hair growth.

Regenerative repair is essential to prevent long-term kidney function issues after obstruction.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Forsythiae Fructus has anti-inflammatory, antibacterial, and antiviral properties, with differences between unripe and ripe forms important for clinical use.

Older mice have stiffer skin with less elasticity due to changes in collagen and skin structure, affecting aging and hair loss.

Moxibustion may help improve ovarian function by changing androgen levels.

Exosomal miRNA-218-5p promotes hair growth and development.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Personalized genomic interventions can effectively manage chronic hair loss.

hUC-MSC secretome can help regrow hair in cases of hair loss.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Quercetin delivery systems are improving its effectiveness for medical use.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Hydrogel-based hair follicle organoids could help treat hair loss and improve drug testing.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

MSC-derived EVs have potential as therapeutic agents but face challenges like production complexity and high costs.

Adipose-derived stem cell exosomes can help reduce skin aging from UV exposure.